Skip to main navigation
  • Stay Connected
  • Contact Us
  • Email Alert
  Menu

BB menu

  • Home
  • About Us
    • Mission and values
    • Leadership team
      • Fredric Price
      • Warren Wasiewski
      • Zohar Argov
      • Chaime Orlev
      • Dana Gelbaum
    • Board of directors
      • Fredric Price
      • Michael Burshtine
      • Thomas I. H. Dubin
      • Colin Foster
      • Robert Friedman
      • Marlene Haffner
      • Dalia Megiddo
      • Ran Nussbaum
      • Ralf Rosskamp
  • Pipeline
    • Mutant protein stabilization
      • Trehalose IV solution
        • OPMD clinical trial
        • SCA3 clinical trial
  • Investors
    • Corporate Governance
    • News & Events
      • News Releases
      • Investor Calendar
    • Financial Information
      • SEC Filings
      • Corporate Presentations
    • Stock Information
      • Stock Chart
      • Historical Stock Lookup
      • Investment Calculator
    • Investor FAQs
    • Contacts
  • News & Events
    • Pipeline updates
      • Archive
    • Trial-related news
      • Archive
    • Latest developments
      • Archive
    • Events and presentations
  • Support & Resources
    • OPMD patients
      • Patient advocacy
    • SCA3 patients
      • Patient advocacy
    • Clinical publications
    • Stay Connected

Stock Chart

Stock Information hr

  • Stock Chart
  • Historical Price Lookup
  • Investment Calculator
  • Print Page
  • RSS Feeds
  • E-mail Alerts

Stay connected with Bioblast Pharma

Sign up to get information and resources for living with rare diseases

Sign up

 

<

Stay connected with Bioblast Pharma

Sign up to get information and resources for living with rare diseases

Sign up

© 2017 Bioblast Pharma Ltd.  |  

Terms of Use  |  Privacy Policy  |  Sitemap